News About: Pharm. Industry
8 local PIs for global clinical studies in Korea.
A local prestige in the muti-national clinical studies has been enormously improved recently, judging by the fact that at the end of 2006 8 local clinical study managers (PIs) were appointed to control a global clinic...
Pfizer to invest 30 billion won for R&D in Korea.
By 2012 Pfizer planned the total 30 billion won of investment to Korea for the development of new drugs according to the MOU made between Chairman Jeff Kindler of Pfizer and Minister Byeon Jae-jin of MOHW at Hyatt hot...
Pediatric safety proof container stirs controversy
The non-observance of some drug makers, who failed to attach the safety proof container for pediatric drugs, has triggered controversy, according to pharmaceutical business sources on June 12.
The sources said that...
3 weight control drugs on hot market competition.
3 leading pharmaceutical companies are going to launch weight control drugs in coming July, which were formulated with a modified or generic ingredient that had kept enjoying its weight control market as a front runne...
KORUS FTA sets new milestone for domestic drug makers
Following the FTA ratification, Korea's pharmaceutical industry needs to enhance productivity and efficiency through restructuring.
But there are some bright spots. Korean companies now can bet on the possibility ...
Drug industries prefer small drug package of 100 than 30 pills.
The Korea Pharmaceutical Manufacturers Association (KPMA) conducted a survey after the enforcement of "Regulation pertaining to the small packaged drug supplies" (KFDA Ordinance No. 2006-46) on the subject of small pa...
Prescription drug sales in 1Q of 2007 rose 7% up.
⼦Top prescription drug sales by company in 1Q of 2007.
Company
1Q of 2007
4Q of 2006
Choongwae
63,937
56,918
Dong-A
63,711
60,613
Hanmi
63,166
56,979
Daew...
M&A against small and medium drug companies to be targeted.
Instead of establishing a new drug company, many attempts of new pharmaceutical business comers have made to enter the drug industry through an M&A with small and medium drug companies.
Asseltec, who purchased Lea...
Diverse types of quit-smoking aids expand whole markets.
The quit-smoking aid markets estimated at a level of 100 billion won are ever growing, thank to the recent public campaign and individual interests on quit-smoking.
The quit-smoking markets may be classified by 3 ...
Daewoong to select prosumer based trade name
On June 7, Daewoong Pharm decided to adopt the trade name of its anti-obesity drug as NVU (I Envy You) based on the opinions of prosumers doctors and pharmacists.
Prosumer is a portmanteau formed by contracting e...
